Prostalund AB (FRA:7PL0) Other Current Receivables: €0.12 Mil (As of Sep. 2025)


FRA:7PL0 Prostalund AB FRA:7PL0
10 GF Score
Price €0.00
GF Value €0.02
! 6 Warning Signs
View Full Analysis

What is Prostalund AB Other Current Receivables?

Prostalund AB FRA:7PL0 10 Other Current Receivables is €0.12 Mil as of Sep. 2025. GuruFocus rates FRA:7PL0 with a GF Score™ of 10/100 and a GF Value™ of €0.02. The stock has 6 warning signs investors should review.

Prostalund AB's Other Current Receivables for the quarter that ended in Sep. 2025 was €0.12 Mil.

Prostalund AB's quarterly Other Current Receivables increased from Mar. 2025 (€0.15 Mil) to Jun. 2025 (€0.16 Mil) but then stayed the same from Jun. 2025 (€0.16 Mil) to Sep. 2025 (€0.12 Mil).

Prostalund AB's annual Other Current Receivables increased from Dec. 2022 (€0.04 Mil) to Dec. 2023 (€0.12 Mil) but then declined from Dec. 2023 (€0.12 Mil) to Dec. 2024 (€0.05 Mil).

Prostalund AB Other Current Receivables Related Terms

Prostalund AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Prostalund AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prostalund AB Other Current Receivables Chart

Prostalund AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.08 0.04 0.12 0.05

Prostalund AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.05 0.15 0.16 0.12
FRA:7PL0
10GF Score
Prostalund AB FRA:7PL0
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prostalund AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.12 Mil mean?
Prostalund AB (FRA:7PL0) has a Other Current Receivables of €0.12 Mil as of Sep. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Prostalund AB and its competitors.
Is Prostalund AB's Other Current Receivables too high?
Prostalund AB's current Other Current Receivables is €0.12 Mil. Overall, Prostalund AB has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Prostalund AB's Other Current Receivables compare to HCA and THC?
Prostalund AB's Other Current Receivables of €0.12 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Prostalund AB and its competitors. Prostalund AB's current Other Current Receivables is €0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prostalund AB stock overvalued right now?
Prostalund AB (FRA:7PL0) has a current Other Current Receivables of €0.12 Mil. The stock's GF Value™ is €0.02, compared to a current price of €0.00 — trading 97.5% below its estimated fair value. The current Other Current Receivables is €0.12 Mil. Prostalund AB's overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Prostalund AB (FRA:7PL0), the current Other Current Receivables is €0.12 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prostalund AB (FRA:7PL0) Overvalued in 2026?

Based on GuruFocus' analysis, Prostalund AB stock appears to be undervalued. The current stock price of €0.00 is trading 97.5% below its estimated GF Value™ of €0.02.

Key valuation signals for FRA:7PL0:

  • Other Current Receivables: €0.12 Mil
  • GF Value™: €0.02 vs. price of €0.00 (97.5% below fair value)
  • GF Score™: 10/100 with 6 warning signs

No single metric tells the full story. See the FRA:7PL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prostalund AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 63
Prostalund AB develops, markets and sells urological products. The Company has a treatment concept (CoreTherm Concept) for personalized heat treatment for the condition benign prostatic hyperplasia, also known as BPH or BPE, which mainly affects men over the age of 50. It has developed a new platform, CoreTherm Eagle which includes an inbuilt computer, real-time temperature reading, patient data storage and inbuilt recommendations for treating physicians.
10GF Score

Get the complete analysis for FRA:7PL0

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price
€0.02
GF Value